Ebglyss Precision - Front page

PRECISION

EBGLYSS^® selectively binds to IL-13 and inhibits downstream signalling with high potency^{1, 4-6}

Figure adapted from Bieber T. 2020² and Moyle M, et al. 2019.⁴

▼ This medicinal product is subject to additional monitoring.

HQ-EBG-2400007

REFERENCES

1. Gonçalves F, et al. Drugs Context. 2021 Mar 30;10:2021-1-7.

2. Bieber T. Allergy. 2020;75:54-62.

3. Tsoi LC, et al. J Invest Dermatol. 2019 Jul;139(7):1480-1489 and supplementary appendix.

4. Moyle M, et al. Exp Dermatol. 2019 Jul;28(7):756–768.

5. Okragly AJ, et al. Dermatol Ther (Heidelb). 2023;13(7):1535–1547.

6. Ultsch M, et al. J Mol Biol. 2013 Apr 26;425(8):1330–1339.